Northwestern Mutual Wealth Management Co. Increases Position in iShares Nasdaq Biotechnology ETF (IBB)

Northwestern Mutual Wealth Management Co. boosted its position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 8.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,467 shares of the financial services provider’s stock after buying an additional 1,724 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in iShares Nasdaq Biotechnology ETF were worth $2,740,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Schroder Investment Management Group bought a new position in iShares Nasdaq Biotechnology ETF during the second quarter valued at approximately $105,000. Benjamin F. Edwards & Company Inc. boosted its stake in iShares Nasdaq Biotechnology ETF by 636.4% during the third quarter. Benjamin F. Edwards & Company Inc. now owns 891 shares of the financial services provider’s stock valued at $109,000 after buying an additional 770 shares during the last quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new position in iShares Nasdaq Biotechnology ETF during the second quarter valued at approximately $134,000. KHP Capital LLC boosted its stake in iShares Nasdaq Biotechnology ETF by 61.1% during the second quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock valued at $159,000 after buying an additional 550 shares during the last quarter. Finally, Private Wealth Advisors Inc. bought a new position in iShares Nasdaq Biotechnology ETF during the second quarter valued at approximately $201,000. 63.62% of the stock is owned by institutional investors.

Shares of IBB stock opened at $110.17 on Friday. iShares Nasdaq Biotechnology ETF has a 1 year low of $100.22 and a 1 year high of $122.97.

COPYRIGHT VIOLATION WARNING: This piece of content was published by WKRB News and is owned by of WKRB News. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.wkrb13.com/2018/11/09/northwestern-mutual-wealth-management-co-increases-position-in-ishares-nasdaq-biotechnology-etf-ibb.html.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More: Earnings Per Share (EPS) Explained

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply